Adam Leckenby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Adam Leckenby has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Azevedo
Storm Therapeutics, Cambridge, UK
1 shared publication - Alex Tonks
Department of Hematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK
1 shared publication - Amanda Gilkes
Department of Haematology, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
1 shared publication Ana Catarina Menezes
1 shared publicationAndrew Pierce
1 shared publicationAnthony D. Whetton
1 shared publication
Latest Publications
- Open Access
- 18 June 2026
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (3)
Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression and blocks myeloid differentiation
- 18 June 2026
- Published by Elsevier in Blood Neoplasia
- Vol. 3 (3)
Open AccessExpression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression and blocks myeloid differentiation
- Open Access
- 24 January 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (2)
Macrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patients
Osteoarthritis (OA) is a leading cause of disability, globally. Despite an emerging role for synovial inflammation in OA pathogenesis, attempts to target inflammation therapeutically have had limited success. A better understanding of the cellular and molecular processes occurring in the OA synovium is needed to develop novel therapeutics. We investigated macrophage phenotype and gene expression in synovial tissue of OA and inflammatory-arthritis (IA) patients. Compared with IA, OA synovial tissue contained higher but variable proportions of macrophages ( P < 0.001). These macrophages exhibited an activated phenotype, expressing folate receptor-2 and CD86, and displayed high phagocytic capacity. RNA sequencing of synovial macrophages revealed 2 OA subgroups. Inflammatory-like OA (iOA) macrophages are closely aligned to IA macrophages and are characterized by a cell proliferation signature. In contrast, classical OA (cOA) macrophages display cartilage remodeling features. Supporting these findings, when compared with cOA, iOA synovial tissue contained higher proportions of macrophages ( P < 0.01), expressing higher levels of the proliferation marker Ki67 ( P < 0.01). These data provide new insight into the heterogeneity of OA synovial tissue and suggest distinct roles of macrophages in pathogenesis. Our findings could lead to the stratification of OA patients for suitable disease-modifying treatments and the identification of novel therapeutic targets.
- 24 January 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (2)
Open AccessMacrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patients
Osteoarthritis (OA) is a leading cause of disability, globally. Despite an emerging role for synovial inflammation in OA pathogenesis, attempts to target inflammation therapeutically have had limited success. A better understanding of the cellular and molecular processes occurring in the OA synovium is needed to develop novel therapeutics. We investigated macrophage phenotype and gene expression in synovial tissue of OA and inflammatory-arthritis (IA) patients. Compared with IA, OA synovial tissue contained higher but variable proportions of macrophages ( P < 0.001). These macrophages exhibited an activated phenotype, expressing folate receptor-2 and CD86, and displayed high phagocytic capacity. RNA sequencing of synovial macrophages revealed 2 OA subgroups. Inflammatory-like OA (iOA) macrophages are closely aligned to IA macrophages and are characterized by a cell proliferation signature. In contrast, classical OA (cOA) macrophages display cartilage remodeling features. Supporting these findings, when compared with cOA, iOA synovial tissue contained higher proportions of macrophages ( P < 0.01), expressing higher levels of the proliferation marker Ki67 ( P < 0.01). These data provide new insight into the heterogeneity of OA synovial tissue and suggest distinct roles of macrophages in pathogenesis. Our findings could lead to the stratification of OA patients for suitable disease-modifying treatments and the identification of novel therapeutic targets.